Michael Babich, formerly the CEO of Insys Therapeutics, was sentenced to 30 months in prison Jan. 22 for his role in a scheme to boost sales of Subsys, a fentanyl spray, Law360 reported.
Insys, the first drugmaker to go bankrupt after opioid litigation, was found to have paid physicians kickbacks to entice them to prescribe more Subsys, which contains the highly addictive opioid, fentanyl.
Mr. Babich pled guilty to conspiracy and mail fraud. He is the fifth of seven former Insys executives to be sentenced, according to Law360.
John Kapoor, the founder of Insys, was convicted last May of racketeering and is scheduled to be sentenced this month. Federal officials have asked for 15 years for Mr. Kapoor.
Read the full article here.